Long-Term Safety and Tolerability of Rivastigmine in Patients With Alzheimer's Disease Switched From Donepezil: An Open-Label Extension Study

OBJECTIVES: The objective of this article is to present safety and tolerability data from the long-term extension phase of a core study conducted in patients with Alzheimer's disease (AD) who were immediately switched to rivastigmine. METHOD: This was a 26-week open-label extension (OLE) of a p...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Figiel, Gary S., Koumaras, Barbara, Meng, Xiangyi, Strigas, John, Gunay, Ibrahim
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Physicians Postgraduate Press, Inc. 2008
Pynciau:
Original Articles
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2629056/
https://ncbi.nlm.nih.gov/pubmed/19158974
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg